Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drug manufacturers-other stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) earnings per share growth forecast for the next five years is 30.00 percent. Cumberland Pharmaceuticals' trailing-twelve-month revenue is $37.50 million.

Depomed Inc (NASDAQ: DEPO) EPS growth forecast for the next five years is 30.00 percent. Depomed's trailing-twelve-month operating margin is 55.30 percent.

POZEN Inc. (NASDAQ: POZN) EPS growth forecast for the next five years is 30.00 percent. POZEN's PEG ratio is 0.49.

CARDIOME PHARMA CORP (NASDAQ: CRME) earnings per share growth forecast for the next five years is 28.00 percent. CARDIOME PHARMA's trailing-twelve-month gross margin is 64.90 percent.